Expanding Technology And Sleep Apnea Initiatives Will Open New Opportunities

Shared on01 May 25
Fair value Decreased 10%

Shared on24 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget has decreased revenue growth from 18.0% to 15.7%.

Shared on02 Apr 25
Fair value Increased 10%

AnalystConsensusTarget has increased revenue growth from 14.1% to 18.0%.

Shared on26 Mar 25
Fair value Decreased 1.91%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.